Takeda Pharmaceutical to Sell Generic JV
Tokyo, Dec. 6 (Jiji Press)--Takeda Pharmaceutical Co. said Friday that it will sell all of its 49 pct stake in generic joint venture Teva Takeda Pharma Ltd. to Israeli partner Teva Pharmaceutical Industries Ltd. for about 55 billion yen.
The transaction is expected to be completed by April 1 next year, subject to regulatory approval, according to the Japanese drugmaker.
(2024/12/06-16:28)
To read a full story, please click here to find out how to subscribe.
BUSINESS
-
12/26 09:58 Hong Kong Fund Ups Stake in Kobayashi Pharma - 12/25 09:32 Toyota to Donate 1 M. Dollars to Trump's Inauguration
- 12/24 17:43 Chocozap Gym to Open at Airport in Kumamoto
- 12/24 16:42 Toyota Eyes Solo Lexus EV Production in Shanghai
- 12/24 10:17 Renault to "Consider All Options" on Honda-Nissan Talks
- 12/23 23:40 JR Kyushu to Withdraw from Passenger Ship Operations
- 12/23 21:44 Japan Post Sues Yamato Transport for 12-B.-Yen Damages
- 12/23 19:36 (Update) Suda, JR Tokai's 1st President, Dies at 93
- 12/23 18:46 Suda, JR Tokai's 1st President, Dies at 93
-
12/23 15:55 INTERVIEW: Nippon Life to Value Digital Use, Social Activities - 12/22 17:03 Honda, Nissan May Announce Start of Merger Talks on Monday
- 12/20 10:00 Japan Snack Makers Try to Keep Long-Selling Products "Fresh"
- 12/20 01:21 Toshiba Picking Up 1 Year after Going Private
- 12/19 23:01 Sony to Become Kadokawa's Top Owner
- 12/19 20:56 KKR Extends Tender Offer for Fuji Soft to Jan. 9
